Pharmaceuticals

Global Viral Clearance Industry Trends: Where the Market Is Headed by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Viral Clearance Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The viral clearance market size has observed substantial and rapid expansion in recent years. This market is forecasted to increase from $0.82 billion in 2024 to $0.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.9%. The market’s past growth can be attributed to a rise in biopharmaceutical production, increased regulatory emphasis on viral safety, the growing prevalence of chronic and infectious diseases, expanding plasma-derived product manufacturing, a rise in outsourcing to CROs and CDMOs, and greater adoption of monoclonal antibodies and recombinant proteins.

The viral clearance market size is projected for substantial growth in the coming years. Its value is anticipated to reach $1.77 billion by 2029, showing a compound annual growth rate (CAGR) of 16.6%. This expansion during the forecast period is driven by several factors, including the rising demand for cell and gene therapies, a heightened focus on biosafety in biomanufacturing, more stringent regulatory validation requirements, the expansion of facilities producing biologics, the growing outsourcing of viral safety testing, and the increasing integration of single-use systems in bioprocessing. Key trends anticipated over the forecast period include the incorporation of high-throughput analytical technologies, the embracing of single-use systems, the development of advanced filtration and chromatography techniques, progress in continuous bioprocessing, and the broadening of contract research and manufacturing services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27444&type=smp

What Are The Key Drivers Of Growth In The Viral Clearance Market?

The viral clearance market is expected to grow due to the increasing incidence of chronic diseases. These conditions are defined as long-term medical issues that develop over time, lasting for months or years and often requiring continuous care or management. Globally, the prevalence of chronic diseases is rising, primarily driven by aging populations, as improved healthcare and living standards lead to longer lifespans and a subsequent increase in age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance is essential in the development of biologics and gene therapies used to treat chronic diseases, ensuring their safety and effectiveness. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion people by 2050. Thus, the escalating prevalence of chronic diseases is fueling the expansion of the viral clearance market.

What Are The Key Segments In The Viral Clearance Market?

The viral clearance market covered in this report is segmented

1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method

2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications

3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users

Subsegments:

1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration

2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography

3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment

4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)

What Long-Term Trends Will Shape The Future Growth Of The Viral Clearance Industry?

Key players within the viral clearance market are prioritizing the implementation of capacity expansion strategies, such as the establishment of large-scale viral vector manufacturing facilities, to cater to the escalating demand for gene therapies and biologics. These substantial viral vector manufacturing facilities represent advanced bioproduction locations equipped with specialized capabilities for producing viral vectors critical for cell and gene therapy, ensuring elevated purity, safety, and adherence to viral clearance standards. For example, in August 2022, Thermo Fisher Scientific, a biotechnology company based in the US, introduced its new 300,000-square-foot commercial viral vector manufacturing facility in Plainville, Massachusetts. This facility effectively doubles its global capacity, facilitates complete end-to-end manufacturing processes, including viral clearance and analytical testing, and supports the prompt and secure commercialization of gene therapies, vaccines, and sophisticated biologics.

Who Are The Major Companies Operating In The Viral Clearance Market?

Major companies operating in the viral clearance market are F Hoffmann-La Roche Ltd., Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Kedrion Biopharma, Nelson Labs, Pall Corporation, Sartorius AG, Syngene International, Microbac Laboratories, Creative Biolabs, Texcell SA, GTP Bioways, and Vironova AB.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/viral-clearance-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Viral Clearance Market?

North America was the largest region in the viral clearance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Viral Clearance Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27444&type=smp

Browse Through More Reports Similar to the Global Viral Clearance Market 2025, By The Business Research Company

Wood Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wood-manufacturing-global-market-report

Wood Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wood-products-global-market-report

Wood Processing Market 2025

https://www.thebusinessresearchcompany.com/report/wood-processing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795